Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-02-29FDA Approved: GLIMEPIRIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for glimepiride by Rising Pharma Holdings, Inc. to update the drug’s labeling.
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Human Faecal Microbiota in Type 2 Diabetes [NA]
Nestlé-sponsored clinical trial update on human fecal microbiota in Type 2 Diabetes. The study status is COMPLETED.
-
FDA approval · 2016-02-29FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a generic Glyburide and Metformin Hydrochloride tablet under an Original Application (ANDA) by Zydus Pharmaceuticals (USA) Inc.
-
EMA guidance · 2016-02-26EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
EMA confirms recommendations to minimize risk of ketoacidosis associated with SGLT2 inhibitors used for diabetes management.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Diabetes-Specific Nutritional Formulas Versus Oatmeal [NA]
Completed clinical trial comparing diabetes-specific nutritional formulas to oatmeal in people with Type 2 Diabetes Mellitus and obesity.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology [Phase 4]
Phase 4 study evaluating whether adding linagliptin to empagliflozin affects islet cell physiology in type 2 diabetes; the trial has complet…
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Diabetes Coaching Study [NA]
A clinical trial update indicates that a diabetes coaching study for Type 2 Diabetes Mellitus, sponsored by the West German Center of Diabet…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes [Phase 1, Phase 2]
Karolinska Institutet completed a Phase 1/2 trial evaluating an arginase inhibitor and its effect on microvascular endothelial function in T…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Diabetes in India Nutrition Guidelines Study (DINGS) [NA]
An update on the completed Diabetes in India Nutrition Guidelines Study (DINGS) evaluating nutrition guidelines for Type 2 diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Feel4Diabetes-study [NA]
Clinical trial update for the Feel4Diabetes study (NCT02393872) sponsored by Harokopio University, investigating obesity and type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluated the safety and efficacy of combining empagliflozin with metformin for 24 weeks in treatment-naive adults with Type…
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30
This completed observational study evaluated diabetes patients (Type 1 and Type 2) who switched from human premixed insulin to NovoMix 30.
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: Bariatric Surgery on the West Coast of Norway (Vestlandet)
An update on a bariatric surgery trial in Vestlandet, Norway, focusing on weight loss, type 2 diabetes mellitus, and urinary incontinence.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Effects of Chronic Dietary Exposure to Branched Chain Amino Acids [NA]
An update on a completed clinical trial evaluating the effects of chronic dietary exposure to branched-chain amino acids in individuals with…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Prenatal Nutrition and Adult Disease
An update on a completed clinical trial examining whether prenatal nutrition influences risk of adult cardiovascular and metabolic diseases,…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT
This is an ancillary analysis of the IDNT trial, reporting serum total homocysteine and C-reactive protein measurements in participants with…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Modulation of Human Myocardial Metabolism by GLP-1 Dose Response [Phase 2, Phase 3]
This clinical trial update summarizes Phase 2/3 results on GLP-1 modulation of human myocardial metabolism in adults with type 2 diabetes an…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020) [Phase 1]
Phase 1 study of ertugliflozin in healthy male participants completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM [Phase 1]
This Phase 1 trial update reports the results of a drug-drug interaction study evaluating HMS5552, a glucokinase activator, in combination w…
-
CLINICAL_TRIALS research · 2016-02-17Clinical Trial Update: Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes
Clinical trial update on digestive tract reconstruction after gastrectomy for gastric cancer in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM [Phase 4]
Phase 4 clinical trial investigating the effect of sitagliptin on endothelial function during an oral glucose tolerance test in adults with …
-
FDA approval · 2016-02-16FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Toujeo (insulin glargine) submitted by Sanofi-Aventis U.S. LLC. The approval pertains to cha…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease [Phase 3]
Phase 3 safety evaluation of Technosphere insulin in adults with Type 1 or Type 2 diabetes who also have moderate COPD or asthma; the study …
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients [Phase 4]
Phase 4 clinical trial assessing the effect of prostaglandin I2 on endothelial cell function in Type 2 diabetes mellitus patients has comple…
-
EMA guidance · 2016-02-12SGLT2 inhibitors: PRAC makes recommendations to minimise risk of diabetic ketoacidosis
PRAC recommends measures to minimize the risk of diabetic ketoacidosis with SGLT2 inhibitors.